Medicare Enrolled
Dr. W Martin, M.D.
Infectious Disease · Roseville, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Martin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Martin
Dr. W Martin is an infectious disease specialist in Roseville, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Martin performed 673 Medicare services across 358 unique beneficiaries.
Between the years covered by Open Payments, Dr. Martin received a total of $24,308 from 70 pharmaceutical and/or device companies across 1115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Martin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 46% volume in CA
$24,308 industry payments
Medicare Practice Summary
Medicare Utilization ↗673
Medicare services
Top 46% in CA for infectious disease
358
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~35 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
224 | $102 | $300 |
| Skin and tissue removal, 20 sq cm or less This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller. |
209 | $48 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
55 | $142 | $405 |
| Additional skin and tissue removal, per 20 sq cm This code covers the removal of skin and tissue for each additional 20 square centimeters or less beyond the initial procedure. |
51 | $20 | $60 |
| New patient office visit, complex (60-74 min) | 40 | $165 | $585 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $108 | $465 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $74 | $200 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
17 | $59 | $235 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
15 | $22 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,308
Total received (2018-2024)
Avg $3,473/year across 7 years
Top 9% in CA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
1,115
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,831 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$477 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,483
2023
$4,389
2022
$3,633
2021
$3,334
2020
$1,817
2019
$2,713
2018
$2,940
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$1,252
ViiV Healthcare Company
$841
AstraZeneca Pharmaceuticals LP
$713
United Therapeutics Corporation
$340
GlaxoSmithKline, LLC.
$310
Astellas Pharma US Inc
$309
ABBVIE INC.
$278
Insmed, Inc.
$180
Regeneron Healthcare Solutions, Inc.
$174
Amgen Inc.
$169
GENZYME CORPORATION
$160
Merck Sharp & Dohme LLC
$144
PFIZER INC.
$90
Mylan Specialty L.P.
$76
La Jolla Pharmaceutical Company
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
Baxter Healthcare
$60
Pulmonx Corporation
$49
Bayer Healthcare Pharmaceuticals Inc.
$44
Grifols USA, LLC
$42
Electromed, Inc.
$39
Philips North America LLC
$29
Monaghan Medical Corporation
$26
Janssen Pharmaceuticals, Inc
$21
Melinta Therapeutics, LLC
$14
Top 3 companies account for 51.2% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$5,107
ViiV Healthcare Company
$2,566
GlaxoSmithKline, LLC.
$2,107
AstraZeneca Pharmaceuticals LP
$1,965
Merck Sharp & Dohme Corporation
$1,066
Boehringer Ingelheim Pharmaceuticals, Inc.
$999
Astellas Pharma US Inc
$900
ABBVIE INC.
$713
United Therapeutics Corporation
$582
Janssen Biotech, Inc.
$580
Merck Sharp & Dohme LLC
$542
Insmed, Inc.
$503
Regeneron Healthcare Solutions, Inc.
$492
Theratechnologies Inc.
$466
Actelion Pharmaceuticals US, Inc.
$359
Allergan Inc.
$327
Takeda Pharmaceuticals U.S.A., Inc.
$321
Grifols USA, LLC
$300
Baxter Healthcare
$275
Amgen Inc.
$274
Janssen Products, LP
$255
AbbVie Inc.
$234
Electromed, Inc.
$224
PFIZER INC.
$208
MAYNE PHARMA INC.
$198
Mylan Specialty L.P.
$192
Allergan, Inc.
$170
Kerecis Limited
$160
GENZYME CORPORATION
$160
Advanced Respiratory, Inc
$143
Shire North American Group Inc
$139
La Jolla Pharmaceutical Company
$139
Harmony Biosciences LLC
$126
Sunovion Pharmaceuticals Inc.
$122
Paratek Pharmaceuticals, Inc.
$108
Philips Electronics North America Corporation
$103
Bayer Healthcare Pharmaceuticals Inc.
$91
Shionogi Inc
$84
Mallinckrodt Hospital Products Inc.
$74
Bayer HealthCare Pharmaceuticals Inc.
$66
Melinta Therapeutics, Inc.
$66
Genentech USA, Inc.
$61
Pulmonx Corporation
$49
Inspire Medical Systems, Inc.
$47
Kaleo, Inc.
$47
Circassia Pharmaceuticals Inc
$46
Mallinckrodt LLC
$45
CSL Behring
$42
Teva Pharmaceuticals USA, Inc.
$39
Janssen Pharmaceuticals, Inc
$38
Melinta Therapeutics, LLC
$37
Philips North America LLC
$29
ADVANCED RESPIRATORY, INC
$26
Monaghan Medical Corporation
$26
Vyera Pharmaceuticals, LLC
$23
Horizon Therapeutics plc
$21
HARMONY BIOSCIENCES LLC
$20
Biogen, Inc.
$20
Horizon Pharma plc
$19
Alexion Pharmaceuticals, Inc.
$18
PORTOLA PHARMACEUTICALS, LLC
$18
Smith & Nephew, Inc.
$17
Fisher & Paykel Healthcare Inc
$17
Covis Pharma GmBH
$16
BioCryst Pharmaceuticals, Inc.
$15
Advanced Accelerator Applications
$15
EMD Serono, Inc.
$14
Bio Products Laboratory USA, Inc.
$14
HARTMANN USA, INC.
$13
Ferring Pharmaceuticals Inc.
$12
Top 3 companies account for 40.2% of all-time payments
Associated products mentioned in payments ›
(6299) DreamWear · (7999) SRC Undivided · (8275) DreamStation Cpap Auto · (AK6) Vest Therapy · ACTHAR · ACTIMMUNE · AIRSUPRA · ALVESCO · AMBISOME · ANDEXXA · ANORO · ANORO ELLIPTA · APRETUDE · AVYCAZ · Adempas · Aerobika · AmBisome · Arikayce · Auvi-Q · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · Baxdela · Biktarvy · CABENUVA · CHANTIX · CHARTIS CATHETER · CINQAIR · CRESEMBA · CUVITRU · Cresemba · DALVANCE · DELSTRIGO · DIFICID · DORYX · DOVATO · DUPIXENT · Daraprim 30 Tablet in 1 Bottle · Descovy · EGRIFTA · ELIQUIS · Esbriet · FASENRA · FIRAZYR · Fetroja · GIAPREZA · GLASSIA · Gammaplex · Haegarda · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INSPIRE · ISENTRESS · JULUCA · Kcentra · Kerecis Omega3 SurgiClose · Kimyrsa · LONHALA MAGNAIR · Lutathera · NIOX VERO · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PIFELTRO · PREVNAR 13 · PREZCOBIX · Perforomist · Personal Care Undiv · Personal Care Undivided · Prolastin-C · Prolastin-C Liquid · RUKOBIA · Rezzayo · SEROSTIM · SHINGRIX · SMARTVEST · SPINRAZA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · SYMTUZA · Santyl · Symtuza · TAGRISSO · TAKHZYRO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TROGARZO · TUDORZA PRESSAIR · TYVASO · Tavneos · The Vest System Model 105 Home Care · ULTOMIRIS · UPTRAVI · Utibron · Vabomere · Veklury · WAKIX · WINREVAIR · Wakix · XARELTO · XERAVA · YUPELRI · Yupelri · ZEPATIER · ZERBAXA · Zetuvit Plus
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for infectious disease in CA.
Geographic Context
Infectious diseases within 10 mi
57
Per 100K population
13.8
County median income
$114,678
Nearest hospital
SUTTER ROSEVILLE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Martin is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Martin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Martin performed 224 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Martin receive payments from pharmaceutical companies?
Yes. Dr. Martin received a total of $24,308 from 70 companies across 1,115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martin's costs compare to other infectious diseases in Roseville?
Dr. Martin's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Roseville
Browse infectious diseases in Roseville ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in CA
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in CA
Which CA infectious diseases receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology